Abstract:Background: The incidence of duodenal adenocarcinoma is increasing, with limited studies on this disease published. This multicenter retrospective study aimed to analyze the clinicopathologic features of duodenal adenocarcinoma and identify prognostic factors for postoperative survival. Methods: Demographic characteristics, clinicopathologic features, treatment outcomes, and survival of patients with duodenal adenocarcinoma undergoing surgical treatment at 16 Chinese medical centers from 2012 to 2023 were retrospectively analyzed. Results: Among the 2,189 patients with duodenal adenocarcinoma included, 50.07% had extra-ampullary duodenal adenocarcinoma and 49.93% had peri-ampullary duodenal adenocarcinoma. The 1-, 3-, and 5-year overall survival rates for patients who underwent radical surgery were 91.78%, 69.30%, and 55.86%, respectively. The median overall survival was 73 months (range, 64-84), and the median progression-free survival was 64 months (range, 52-76). No differences in survival were observed between the laparotomy and minimally invasive surgery groups (log-rank P = .562); furthermore, no significant between-group differences in operation time, lymph node dissection, postoperative complications, or in-hospital mortality were observed (P > .05). The minimally invasive surgery group experienced less intraoperative blood loss (250 mL vs 100 mL, P < .001), fewer intraoperative blood transfusions (24.97% vs 18.84%, P = .002), and shorter hospital stays (28 days vs 23 days, P < .001). Multivariate Cox regression analysis revealed that advanced age, advanced stage, longer operation time, intraoperative blood transfusion, and postoperative hemorrhage were independent risk factors for poor prognosis. Conclusion: Radical surgery was associated with favorable overall survival among patients with duodenal adenocarcinoma, and no difference in survival was observed between patients with extra-ampullary duodenal adenocarcinoma and peri-ampullary duodenal adenocarcinoma. Minimally invasive surgery is a reliable alternative for duodenal adenocarcinoma treatment.

Endoscopic Resection Outcomes of Duodenal Brunner's Gland Adenoma

Analysis on clinical features of duodenal Brunner's gland adenoma

Endoscopic Resection For The Treatment Of Duodenal Brunner'S Adenomas

Endoscopic Treatment of Duodenal Brunner Adenoma

The Characteristics and Treatment Outcomes of 71 Duodenal Brunner's Gland Adenomas with Endoscopic Submucosal Dissection.

Surgical Management and Outcomes of Duodenal Gastrointestinal Stromal Tumors.

A Case Report of Endoscopic Resection for the Treatment of Duodenal Brunner's Gland Adenoma with Upper Gastrointestinal Bleeding

S3206 Novel Trans-Pyloric Gastric Fixation to Facilitate ESD Resection of a Large Duodenal Brunner Gland Subpithelial Mass

Microscopic transduodenal excision of an ampullary adenoma: A case report and review of the literature

Values of Endoscopic Ultrasonography for Diagnosis and Treatment of Duodenal Protruding Lesions

S4906 Brunner Gland Adenoma: A Rare Cause of Upper Gastrointestinal Bleeding

A 10 cm pedunculated duodenal Brunner gland hamartoma, case report and literature review

Giant Brunner's Gland Adenoma of Duodenal Bulb:A Case Report

The Brunner adenoma of the duodenum with positive fecal occult blood and anemia: A case report

Current status and challenges of endoscopic treatments for duodenal tumors

A Rare Gastric Neuroendocrine Carcinoma Coexisting with Brunner's Gland Adenoma: A Case Report

S4110 Hyperplasia of Brunners' Glands as a Cause of Gastrointestinal Bleeding in a Young Patient: An Endoscopic Approach

Endoscopic Treatment of Duodenal Submucosal Tumor

Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience

Treatment outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumors

Clinicopathologic features and surgery-related outcomes of duodenal adenocarcinoma: A multicenter retrospective study